Get all your news in one place.
100’s of premium titles.
One app.
Start reading
The Independent UK
The Independent UK
Lifestyle
Inga Parkel

Oasis guitarist Bonehead given cancer all-clear: ‘Into recovery now and see you all soon’

Getty Images

Oasis guitarist Paul Arthurs – better known by his stage name Bonehead – has given fans a promising update on his cancer status after undergoing treatment in June.

The musician – who had been playing as part of Liam Gallagher’s live band – was diagnosed with tonsil cancer earlier this year.

In a new update, shared on Twitter on Thursday (29 September), Bonehead wrote: “I had a full scan 10 days ago and it’s all clear, it’s gone.”

“Thank you so much all of you for the messages I’ve had throughout, you’ve helped more than you know,” he said, further thanking the team at The Christie NHS foundation.

“Into recovery now and see you all soon,” he added.

Gallagher celebrated the news, writing on Twitter: “Yes Bonehead, we knew you’d kick its arse. Sooooo f***ing happy Guinness.”

The good news comes shortly after his course of treatment in June, which included radiotherapy and chemotherapy sessions.

At the time, he told fans: “I’m feeling the pain right now but I’m in recovery and things can only get better from here.”

He had undergone the treatment at The Christie NHS Foundation Trust in Manchester.

Bonehead was a founding member of Oasis. He announced he was leaving the group in 1999, during the recording of Oasis’s fourth album, Standing on the Shoulder of Giants, explaining that he wished to spend more time with his family.

He continued to work with Liam Gallagher over the years, and had been scheduled to perform with him this summer.

Sign up to read this article
Read news from 100’s of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.